Visit
Apply
Give

Department of Pharmacy Practice

Martin J. Ohlinger, Pharm.D., RPh, BCCCP, FCCM

PUBLICATIONS AND JOURNALS

Book Chapters / Academic Publications

  1. Ohlinger MJ. Management of Healthcare Acquired Pneumonia and Ventilator Associated Pneumonia. Critical Care Self-Assessment Program. American College of Clinical Pharmacy, Kansas City, MO. Copyright 2016.
  2. Barletta JF, Cooper B, Ohlinger MJ.  “Drug Induced Coagulation Disorders”.  Chapter 18: Drug Induced Coagulation Disorders, in Drug Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment.  Editor, Papadopoulos J et al. Society of Critical Care Medicine, 2012.
  3. “The Injectable Drug Reference”, Second Edition, Bioscientific Resources. Editor, Martin SJ. Society of Critical Care Medicine, 2006.  Ohlinger MJ – contributing author.
  4. Martin SJ, Ohlinger MJ. “Nosocomial Gram-Negative Infections” in PSAP: Pharmacotherapy Self-Assessment Program. Fifth Edition. American College of Clinical Pharmacy, Kansas City, MO. Copyright 2005.

Original Contributions

Peer-Reviewed

  1. Amer M, Buschor K, Ohlinger MJ. The impact of the location of sepsis presentation on compliance to centers for Medicare and Medicaid Services (CMS) sepsis core measures: a retrospective cohort study. J Emerg Med Trauma Surg Care 2017;5(1):021.
  2. Barletta JF, Cooper B, Ohlinger MJ. Adverse drug events associated with disorders of coagulation. Crit Care Med 2010;38 (Suppl.):S198-S218.
  3. Dotson BD, Ohlinger MJ. Letter to the editor re: Empiric antimicrobial therapy for healthcare and ventilator associated pneumonia.  Crit Care Med 2008;36(5):1696-7.
  4. Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury.  Ann Pharmacother2008;42:247-52.
  5. Fish DN, Ohlinger MJ. Antimicrobial resistance: factors and outcomes.  Critical Care Clinics 2006;22(2):291-311.
  6. Ohlinger MJ, Rhoney DH.  Neuromuscular blocking agents in the neurosurgical intensive care unit.  Surg Neurol  1998;49:217-21.

Non-Peer Reviewed

  1. Sanuth B, Ohlinger MJ, Martin SJ.  Ceftobripole and doripenem: New antibiotics for potential use in critical illness. Critical Connections 2009; 8(3):18-9.
  2. Ohlinger MJ.  Analgesia in the ICU since the 2002 SCCM guidelines: what’s new? Critical Connections 2004;3(2):12.
  3. Ohlinger MJ.  Pharmacist participation in intensive care unit rounds reduces medication errors.  Ohio Pharmacist.  1999;48(10);11.
  4. Ohlinger MJ.  Pharmacists reducing medication errors.  The Ohio Society of Health-System Pharmacists Bulletin.  1999;19(5):1.
  5. “Non-Traditional Pharm.D. Courseware:Physical Assessment and History Taking Module”.  Ohlinger MJ. Council of Ohio Colleges of Pharmacy Non-Traditional PharmD Program Curriculum.

Case Reports, Peer-Reviewed

  1. Rose L, Ohlinger MJ, Mauro VF.  A hypertensive reaction induced by concurrent use of selegiline and dopamine.  Ann Pharmacother 2000;34:1020-4.

Abstracts and Poster Presentations

  1. Amer M, Buschor K, Cole K, Ohlinger MJ.  Identification and management of early sepsis at an academic medical center: Who does is better? Oral presentation (Amer) at the Ohio Pharmacy Residency Conference, Ohio Northern University, May 2017.
  2. Outcomes from an Integrated IPE Course across Multiple Healthcare Professions. Sexton M, Masterson M, Metz AE, Ohlinger MJ, Peeters MJ. Collaborating Across Borders V 2015 Conference. Roanoke, VA.
  3. Witt B, Jung R, Ohlinger, MJ.  Efficacy and safety of levetiracetam for seizure prophylaxis in traumatic brain injury.  Oral presentation (Witt) at the Ohio Pharmacy Residency Conference, Ohio Northern University, May 2015.
  4. Reale M, Buschor K, Ohlinger, MJ.  Treatment of post-anoxic encephalopathy beyond 48 hours: impact on outcomes and cost. Oral presentation (Reale) at the Ohio Pharmacy Residency Conference, Ohio Northern University, May 2015.
  5. Bassil EH, Peeters MJ, Ohlinger MJ, Zitko KL, Schmude KA, Schneiderman JW, Chen Y. Using simulation for instruction of rapid-sequence intubation and reinforcing basic life support among third-year PharmD students. Pharmacotherapy. 2015; 35(5):e68.
  6. Sanuth B, Jung R, Ohlinger MJ.  Prospective Comparison of Daytime vs. Nighttime Sedatives and Opioid Analgesics Use in the Medical and Surgical Intensive Care Units.  Crit Care Med. 2009;37(12 suppl):A493.  Poster Presentation at 2010 Society of Critical Care Medicine Annual Congress in Miami, FL.
  7. Sanuth B, Jung R, Ohlinger MJ.  Prospective Comparison of Daytime vs. Nighttime Sedatives and Opioid Analgesics Use in the Medical and Surgical Intensive Care Units.  Oral presentation (Sanuth), 2009 Great Lakes Pharmacy Residency Conference, Purdue University, West Lafayette, IN.
  8. Aboezz R, Ohlinger MJ.  Use of insulin glargine with tight glycemic control in a surgical intensive care unit.  Oral presentation (Aboezz) at 2007 Great Lakes Pharmacy Residency Conference, Purdue University, West Lafayette, IN.
  9. George S, Ohlinger M, Martin SJ.  Development and Implementation of an ICU Sedation Protocol.  Oral Presentation (George) at 2003 Great Lakes Pharmacy Residency Conference, Purdue University, West Lafayette, IN.
  10. Ohlinger MJ, Black CD.  Influence of Teaching Assistantships on Choosing a Career in Academia.  Poster Presentation at AACP Annual Meeting and Seminars, July 12-17, 2002. Kansas City, MO.
  11. Sahloff E, Martin SJ, Ohlinger MJ.  Intensive glucose control in patients receiving parenteral nutrition.  Oral Presentation (Sahloff) at 2001 Great Lakes Pharmacy Residency Conference, Madison, WI.
  12. Ohlinger MJ, Ruffing M, Edwards D, Lavine D.  The Relative Bioavailability of Quinapril in Critically Ill Patients.  Oral presentation at 1996 Great Lakes Pharmacy Residency Conference, Indianapolis, IN.
  13. Ohlinger MJ, Grillo J, Elswick RK, Gonzalez E.  A Comparison of IV Admixture Time of Three Brands of Ceftazidime: a Time-in-Motion Study.  Poster presentation at 1994 ASHP Midyear Meeting.
Last Updated: 7/15/24